Actually ment the whole company. I believe they were a Genentech spinoff or at least it was started by a bunch of empoyees.
Yeah not too many companies give as detailed royalties as Ligand. Some if you listen to enough calls (get a sense for how management talks) and read a bit between the lines can get a descent estimate. Others will basically say without saying basically acknowledging what "the street" is modeling.
Do appreciate your ReadMe! My being on the fence is in part that things furherest slong are in phase 2 still a bit away from income producing royalties. Have a bunch of debt still and even with the cuts burn is still too high IMO. I wouldn't be suprised if they sell a royalty or two and not sure how I'd feel about that.
Market Data 
Markets 
AI
